Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

buy

Cytokinetics Inc. buy Barclays PLC

Cytokinetics Inc.

Start price

€55.52

/ 50%

Target price

06.04.27

Performance (%)

Price

Summary

This prediction is currently active. The BUY prediction by Barclays_PLC for Cytokinetics Inc. is nearly unchanged. This prediction currently runs until 06.04.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this prediction

Performance without dividends (%)

Name	1w
Cytokinetics Inc.
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by Barclays_PLC for this prediction

In the thread Discuss Cytokinetics Inc.

Prediction Buy

Perf. (%)

Target price 82.470

Change

Ends at

Cytokinetics (CYTK) had its price target raised by Barclays PLC from $87.00 to $95.00. They now have an "overweight" rating on the stock.

Ratings data for CYTK provided by MarketBeat

0

Stopped prediction by Barclays_PLC for Cytokinetics Inc.

Cytokinetics Inc.

Start price

Target price

Perf. (%)

€53.50

28.01.27

50%

Cytokinetics Inc.

Start price

Target price

Perf. (%)

€41.60

03.09.26

50%

Cytokinetics Inc.

Start price

Target price

Perf. (%)

€29.00

08.05.26

50%

Cytokinetics Inc.

Start price

Target price

Perf. (%)

€33.60

24.04.26

50%

Cytokinetics Inc.

Start price

Target price

Perf. (%)

€46.40

23.05.25

50%